Cerebral protective effect of flunarizine in a canine model of cerebral ischaemia.
To test the effect of flunarizine on cerebral ischaemia, 15 dogs were subjected to ischaemia, using the 'canine model of the completely ischaemic brain regulated with a perfusion method' in which the cerebral blood flow (CBF) can be fully regulated. Five animals served as untreated controls, 10 received flunarizine, a calcium antagonist (1 mg/kg in 5 dogs and 3 mg/kg in 5 dogs), before the ischaemic period. After 1 h CBF was restored and recovery of the electrical activity of the brain and the degree of brain swelling were observed for 3 h. At the end of the experiments, the degree of extravasation of Evans blue was examined. Remarkable recovery of EEG was found in the groups given flunarizine when compared with untreated controls. However, no significant difference was found between untreated controls and flunarizine treated groups for the degree of brain swelling and the degree of extravasation of Evans blue. These results suggest that the treatment of flunarizine is of benefit for functional recovery against cerebral ischaemia, but does not suppress ischaemic brain oedema.
Abiko
H
H
Division of Neurosurgery, Tohoku University School of Medicine, Sendai, Japan.
Mizoi
K
K
Suzuki
J
J
Oba
M
M
Yoshimoto
T
T
D000818:Animals; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography; D005444:Flunarizine / Q000627:therapeutic use*; D002546:Ischemic Attack, Transient / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology
D002121:Calcium Channel Blockers; D005444:Flunarizine